CIDP and MMN
Cross-source consensus on CIDP and MMN from 1 sources and 3 claims.
1 sources · 3 claims
How it works
Risks & contraindications
Comparisons
Highlighted claims
- CIDP and MMN are chronic autoimmune neurological disorders causing muscle weakness, impaired fine motor skills, and loss of reflexes. — Benefits and challenges in everyday life for patients performing subcutaneous immunoglobulin treatment at home: a qualitative interview study
- CIDP/MMN patients previously required four to five days of hospitalisation per month for IVIg treatment. — Benefits and challenges in everyday life for patients performing subcutaneous immunoglobulin treatment at home: a qualitative interview study
- For one CIDP/MMN patient, scheduling IVIg on weekends to preserve work attendance had strained family life, a conflict resolved completely by at-home SCIg. — Benefits and challenges in everyday life for patients performing subcutaneous immunoglobulin treatment at home: a qualitative interview study